Albert Health
Developer and operator of a mobile-first digital health platform for chronic disease management. The platform combines machine learning personalization, voice-enabled user interfaces, and clinically grounded guidance to support patient self-management, remote care workflows, and real-world evidence generation. The company states compliance with information security, privacy and medical software/device quality standards and publishes procedures for personal data processing, transfer, retention/anonymization, and data-subject rights handling.
Industries
Nr. of Employees
small (1-50)
Albert Health
HQ: Acıbadem Üniversitesi Kuluçka Merkezi, İstanbul, Türkiye
Products
Mobile chronic disease management application
A mobile application that delivers personalized education, medication tracking, voice-first navigation, remote-care features and data capture for chronic-disease cohorts.
Mobile chronic disease management application
A mobile application that delivers personalized education, medication tracking, voice-first navigation, remote-care features and data capture for chronic-disease cohorts.
Services
Provision of a mobile and enterprise-integrated platform to support patient self-management, remote care workflows, medication tracking, and data collection for clinical programmes.
Collaborative support for clinical studies including patient recruiting, digital outcome instrument validation and remote data collection.
Provision of a mobile and enterprise-integrated platform to support patient self-management, remote care workflows, medication tracking, and data collection for clinical programmes.
Collaborative support for clinical studies including patient recruiting, digital outcome instrument validation and remote data collection.
Expertise Areas
- Digital chronic disease management
- AI-driven personalization for healthcare
- Voice-enabled patient engagement
- Clinical study partnerships and patient recruiting
Key Technologies
- Natural language / voice-assistant systems
- Machine learning for personalization
- Mobile health applications (mHealth)
- Remote monitoring and telehealth workflows
News & Updates
Company video presenting the platform and patient-centred approach.
Completed studies listed include growth hormone deficiency outcomes and behaviour-change interventions in diabetes; these are cited as completed on the clinical trials page.
Ongoing clinical studies and patient recruiting activities in diabetes, obesity, hemophilia, multiple sclerosis, heart failure and asthma noted on the clinical trials page.
Company video presenting the platform and patient-centred approach.
Completed studies listed include growth hormone deficiency outcomes and behaviour-change interventions in diabetes; these are cited as completed on the clinical trials page.
Ongoing clinical studies and patient recruiting activities in diabetes, obesity, hemophilia, multiple sclerosis, heart failure and asthma noted on the clinical trials page.